Nathaniel Joshua Silverman's Insider Trades & SAST Disclosures
Nathaniel Joshua Silverman's most recent trade in Petros Pharmaceuticals Inc was a trade of 1,000,000 Common Stock done . Disclosure was reported to the exchange on Feb. 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nathaniel Joshua Silverman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 1,000,000 | 1,011,237 | - | 0 | Common Stock | |
| AYRO Inc | Joshua Nathaniel Silverman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 146,052 | 189,323 | - | 0 | Common Stock | |
| AYRO Inc | Joshua Nathaniel Silverman | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 97,368 | 97,368 | - | - | Cash-Settled Restricted Stock Units | |
| AYRO Inc | Joshua Nathaniel Silverman | Director, Executive Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Dec 2024 | 6,166 | 43,271 | - | 0 | Common Stock | |
| Femasys Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2024 | 17,600 | 17,600 | - | - | Stock Option (Right to Buy) | |
| Synaptogenix Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| Petros Pharmaceuticals Inc | Joshua Silverman Nathaniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 01 Aug 2023 | 12,740 | 395,493 | - | 0.8 | 10,386 | Common Stock |
| TNF Pharmaceuticals Inc. | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to Buy) | |
| Petros Pharmaceuticals Inc | Nathaniel Joshua Silverman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 6,722 | 0 | - | - | Restricted Stock Units | |
| Petros Pharmaceuticals Inc | Nathaniel Silverman Joshua | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 6,722 | 11,237 | - | - | Common Stock | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 39,000 | 39,000 | - | - | Stock Option (Right to Buy) | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 197,333 | 420,160 | - | 0 | Common Stock | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Sale of securities on an exchange or to another person at price $ 0.71 per share. | 30 Jan 2023 | 7,171 | 222,827 | - | 0.7 | 5,108 | Common Stock |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2023 | 2,515 | 4,515 | - | - | Common Stock | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2023 | 2,515 | 0 | - | - | Restricted Stock Units | |
| Synaptogenix Inc | Joshua Nathaniel Silverman | Director | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 16 Dec 2022 | 19,012 | 38,238 | - | 1.2 | 22,280 | Common Stock, par value $0.0001 per share |
| Synaptogenix Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 11 May 2022 | 12,855 | 237,169 | - | 0.8 | 10,541 | Common Stock |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 11 May 2022 | 7,171 | 229,998 | - | 0.6 | 4,245 | Common Stock |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 67,227 | 67,227 | - | - | Restricted Stock Units | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 114,729 | 250,024 | - | 0 | Common Stock | |
| Synaptogenix Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 42,250 | 57,250 | - | 0 | Common Stock, par value $0.0001 per share | |
| Synaptogenix Inc | Joshua Nathaniel Silverman | Director | Purchase of securities on an exchange or from another person at price $ 8.30 per share. | 14 Jun 2021 | 10,000 | 15,000 | - | 8.3 | 83,000 | Common Stock, par value $0.0001 per share |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Sale of securities on an exchange or to another person at price $ 5.17 per share. | 04 Jun 2021 | 39,008 | 135,295 | - | 5.2 | 201,687 | Common Stock |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 42,000 | 174,303 | - | 0 | Common Stock | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 33,400 | 33,400 | - | - | Employee Stock Option (right to buy) | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 24,855 | 24,855 | - | - | Employee Stock Option (right to buy) | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 20,000 | 20,000 | - | - | Common Stock, par value $0.0001 per share | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 2,000 | 2,000 | - | - | Employee Stock Option (right to buy) | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 2,000 | 2,000 | - | - | Employee Stock Option (right to buy) | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 2,000 | 2,000 | - | - | Employee Stock Option (right to buy) | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 2,000 | 2,000 | - | - | Employee Stock Option (right to buy) | |
| Petros Pharmaceuticals Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 1,875 | 1,875 | - | - | Employee Stock Option (right to buy) | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 122,547 | 132,303 | - | 0 | Common Stock | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 122,547 | 132,303 | - | 0 | Common Stock | |
| AYRO Inc | Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 9,756 | 9,756 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges